2019
DOI: 10.1002/jcp.28284
|View full text |Cite
|
Sign up to set email alerts
|

LncRNA CRNDE regulates the proliferation and migration of vascular smooth muscle cells

Abstract: Restenosis after angioplasty or stent is a major clinical problem. While long noncoding RNAs (lncRNAs) are implicated in a variety of diseases, their role in restenosis is not well understood. This study aims to investigate how dysregulated lncRNAs and messenger RNAs (mRNAs) contribute to restenosis. By microarray analysis, we identified 202 lncRNAs and 625 mRNAs (fold change > 2.0, p < 0.05) differentially expressed between the balloon‐injured carotid artery and uninjured carotid artery in the rats. Among dif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(20 citation statements)
references
References 32 publications
0
20
0
Order By: Relevance
“…We obtained ceRNA networks with 8 DElncRNAs, 13 DEmiRNAs, and 19 DEmRNAs. CRANDE plays a role in tumor proliferation, migration, and the occurrence of many other diseases ( Zhou et al, 2019a ; Xie et al, 2020 ). CRANDE interacts with TLR3, and both correlate with advanced disease inflammation in sepsis patients ( Yang et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…We obtained ceRNA networks with 8 DElncRNAs, 13 DEmiRNAs, and 19 DEmRNAs. CRANDE plays a role in tumor proliferation, migration, and the occurrence of many other diseases ( Zhou et al, 2019a ; Xie et al, 2020 ). CRANDE interacts with TLR3, and both correlate with advanced disease inflammation in sepsis patients ( Yang et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Significantly, the development of restenosis was due to neointima hyperplasia chiefly caused by aberrant VSMC proliferation and migration after vascular wall injury. 28 Although the improvement of drug-eluting stents (DESs) significantly reduced the in-stent stenosis incidence rate by releasing antiproliferative drugs to inhibit VSMC proliferation and migration, it also posed a new problem: late stent thrombosis due to the side effect of antiproliferative drug inevitably suppressing re-endothelialization. 27 Therefore, it is necessary to explore the regulators and molecular mechanisms in VSMC proliferation and migration.…”
Section: Discussionmentioning
confidence: 99%
“…siRNA, microRNA-146a mimics, and microRNA-146a inhibitor were transfected into HK-2 cells using the Lipofectamine 3000 reagent (Thermo Fisher Scientific). The fulllength CRNDE sequence was inserted into the pcDNA3.1 (Invitrogen) vector to construct the pcDNA3.1-CRNDE overexpression plasmid (O/E); the sequence of CRNDE siRNA (si-CRNDE) was sense, GUGCUCGAGUUAAA UTT, anti-sense, AUUACCACGAGCAT [17].…”
Section: Transfection Crnde Expression Plasmid Crndementioning
confidence: 99%